Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-08-02
1997-04-08
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142285, 5142325, 544 582, 544 70, 544 81, 544118, 544256, A61K 31535, C07D48704
Patent
active
056188145
ABSTRACT:
The invention relates to trisubstituted pyrimido [5,4-d]-pyrimidines of general formula ##STR1## (wherein R.sub.a, R.sub.b and R.sub.c are defined as in claim 1) and the salts thereof, more particularly for pharmaceutical use the physiologically acceptable salts thereof, which have, inter alia, valuable pharmacological properties, particularly in chemotherapy a sensitizing effect on resistant tumors, the use thereof and processes for preparing them.
REFERENCES:
patent: 4329346 (1981-05-01), Jardillier et al.
patent: 4478833 (1984-10-01), Roch et al.
N. Ramu andA. Ramu, Int'l J. Cancer, 43. pp. 487-491 (1989) "Circumvention of Adriamycin Resistance by Dipyridamole Analogues: A Structure Activity Relationship Study".
Bamberger Uwe
Heckel Armin
Mauz Annerose
Devlin Mary-Ellen M.
Dr. Karl Thomae GmbH
Ramsuer Robert W.
Raymond Robert P.
Rieder Wendy E.
LandOfFree
Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397847